Description

AAF-CMK is a TPPII (tripeptidylpeptidase II) inhibitor, shows anti-tumor activity and induces apoptosis. AAF-CMK can be used in leukemia research[1].—Cancer-Kinase/protease–C16H22ClN3O3—-[1]Młnarczuk I, et al. AAF-cmk sensitizes tumor cells to trail-mediated apoptosis. Leuk Res. 2004 Jan;28(1):53-61.–102129-66-8–339.82—-C[C@H](N)C(N[C@@H](C)C(N[C@H](C(CCl)=O)CC1=CC=CC=C1)=O)=O–Cancer–10 mM in DMSO–Apoptosis;Ser/Thr Protease—-Apoptosis;Metabolic Enzyme/Protease–Peptides